相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer
Zaoqu Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Collagen synthesis and gap junctions: the highway for metastasis of ovarian cancer
Yinfeng Lyu et al.
LABORATORY INVESTIGATION (2021)
Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
Romain Cohen et al.
CANCERS (2021)
Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis
Yan Zhuang et al.
BMC CANCER (2021)
COLGALT2 is overexpressed in ovarian cancer and interacts with PLOD3
Ting Guo et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond
Romain Cohen et al.
TARGETED ONCOLOGY (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer The Canadian Cancer Trials Group CO.26 Study
Eric X. Chen et al.
JAMA ONCOLOGY (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Health care provider and patient preparedness for alternative colorectal cancer follow-up; a review
S. M. Qaderi et al.
EJSO (2020)
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li et al.
MOLECULAR CANCER (2020)
Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma
Hulya Sahin Ozkan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis
Qiang Ju et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment
Beilei Wu et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis
Qiang Ju et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway
Jeong-Hwa Baek et al.
CELL DEATH & DISEASE (2019)
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
A. B. Schrock et al.
ANNALS OF ONCOLOGY (2019)
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Suhas Vasaikar et al.
CELL (2019)
Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
Yasutaka Yamada et al.
MOLECULAR ONCOLOGY (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
Rene Jackstadt et al.
CANCER CELL (2019)
Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
Hui Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer
Min-Shan Chen et al.
MOLECULAR CANCER RESEARCH (2019)
Signatures of T-cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification
Eva Jover et al.
FASEB JOURNAL (2018)
Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma
Qingyu Shen et al.
HEPATOLOGY (2018)
Targeting tumor cell plasticity by combined inhibition of NOT CH and MAPK signaling in colon cancer
Eva Marina Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
Chia-Kuang Tsai et al.
Oncotarget (2018)
Cancer Drugs Approved Based on Biomarkers and Not Tumor Type-FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers
Vinay Prasad et al.
JAMA ONCOLOGY (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
PLOD3 promotes lung metastasis via regulation of STAT3
Jeong-Hwa Baek et al.
CELL DEATH & DISEASE (2018)
Roles of PLODs in Collagen Synthesis and Cancer Progression
Yifei Qi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Colorectal cancer population screening programs worldwide in 2016: An update
Mercedes Navarro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease
Rocio Sancho et al.
EMBO REPORTS (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Prolyl-4-hydroxylase a subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition
Gaofeng Xiong et al.
BMC CANCER (2014)
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
A. I. Phipps et al.
BRITISH JOURNAL OF CANCER (2013)
Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Daniele M. Gilkes et al.
CANCER RESEARCH (2013)
Procollagen Lysyl Hydroxylase 2 Is Essential for Hypoxia-Induced Breast Cancer Metastasis
Daniele M. Gilkes et al.
MOLECULAR CANCER RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Laetitia Marisa et al.
PLOS MEDICINE (2013)
A Connective Tissue Disorder Caused by Mutations of the Lysyl Hydroxylase 3 Gene
Antti M. Salo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
The lysyl hydroxylase isoforms are widely expressed during mouse embryogenesis, but obtain tissue- and cell-specific patterns in the adult
Anatti M. Salo et al.
MATRIX BIOLOGY (2006)
Lysyl hydroxylase 3 (LH3) modifies proteins in the extracellular space, a novel mechanism for matrix remodeling
AM Salo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice
K Rautavuoma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity
J Heikkinen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
